-
psnet.ahrq.gov/node/49407/psn-pdf
July 01, 2003 - The principal complication of warfarin therapy is hemorrhage. … inadequate monitoring, co-
administration of medications that interact with warfarin, or inadequate treatment … disorders, but it has a relatively narrow therapeutic window. … Treatment of warfarin-associated coagulopathy with oral
vitamin K: a randomized clinical trial. … Conservative treatment of overanticoagulated patients.
-
psnet.ahrq.gov/node/74271/psn-pdf
January 19, 2022 - Improving shared situation awareness for high-risk
therapies in hospitalized children. … Improving shared situation awareness for high-risk therapies in
hospitalized children. … https://psnet.ahrq.gov/issue/improving-shared-situation-awareness-high-risk-therapies-hospitalized-children … implementation, the percentage of electronic health record (EHR) alerts correctly describing high-risk
therapies … https://psnet.ahrq.gov/issue/improving-shared-situation-awareness-high-risk-therapies-hospitalized-children
-
hcup-us.ahrq.gov/reports/natstats/his95/appdb.htm
January 01, 1999 - 144 145 146 -
147 148
14.3.1 Treatment … , facial fracture or 144 -
dislocation
14.3.2 Treatment … fracture or dislocation 145 -
of radius and ulna
14.3.3 Treatment … - 9396
16.28.3 Other respiratory treatments … 16.42.2 Other phototherapy (newborn) - 9983
16.42.3 Other therapies
-
digital.ahrq.gov/sites/default/files/docs/publication/eaap_trainpresentfinalimplementation_080211comp.pdf
January 01, 2007 - and
improve outcomes” (p93)
“Provide all patients with a written asthma action plan for
daily treatment … frequency of symptoms
Asthma Severity or Control determined by the application
Recommendation for treatment … and improve outcomes” (p93)
“Provide all patients with a written asthma action plan
for daily treatment … Antibiotic use
Written Asthma Action Plans (WAAP) and Peak
Flow meters (PFM)
Effects of early treatment … to
evaluate how/if the treatments are
working
What are we looking for at this follow-
up visit?
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs022938-mitchell-final-report-2017.pdf
January 01, 2017 - While depression is a treatable condition, less than 36% of people with depression
receive effective treatment … .3 Cognitive behavioral Therapy (CBT) is an effective approach to depression
treatment for people with … chronic disease but attending treatment sessions can be challenging.4,5 An
alternative to computerized … scores range from lowest score of 44 to highest
score of 201, with higher scores correlated with higher therapeutic … COPD education and cognitive behavioral therapy group
treatment for clinically significant symptoms of
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0651-131114.pdf
June 20, 2013 - Topic 0552 Low Back Pain NSD FINAL SJ
Diagnosis and Treatment of Low … The nominator is also interested in the harms and benefits of the treatment
options. … interventions for secondary prevention or prevention of flares of low back pain, and
combination therapy … and related therapies, massage, and
various psychological therapies)
6. … What are the comparative benefits and harms of combinations of therapies (versus
single therapies or
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs018665-storch-final-report-2015.pdf
January 01, 2015 - the needs of each client and, depending on the design, could
lack important therapeutic components. … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus
treatment as … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus
treatment as … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus
treatment as … CCBT=Computer-assisted
cognitive-behavioral therapy; TAU=treatment as usual; PARS=Pediatric Anxiety
-
cds.ahrq.gov/sites/default/files/cds/artifact/27811/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/27801/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/27796/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/27781/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/27806/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/27816/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/27771/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/27776/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0264_01-14-2008.pdf
January 01, 2008 - the comparative effectiveness of disease-modifying
antirheumatic drugs (DMARDs) and other medical treatments … for the treatment of
juvenile idiopathic arthritis. … and have no disease-modifying
properties))
Outcome(s): Potential harms and benefits of various treatments … subgroups of patients based on stage of disease, history of
prior therapy, demographics, concomitant … therapies, or comorbidities?
-
effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
January 01, 2010 - gains once active therapy ends. … treatment or across treatments? … including music therapy and nutritional
therapies intended to modify the core symptoms of ASD
Comparators … interventions (e.g., autism, asperger, pervasive development, therapeutics, etc.). … This revision does not eliminate
specific medical therapies from the review as treatments are typically
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
December 09, 2009 - gains once active therapy ends. … treatment or across treatments? … including music therapy and nutritional
therapies intended to modify the core symptoms of ASD
Comparators … interventions (e.g., autism, asperger, pervasive development, therapeutics, etc.). … This revision does not eliminate
specific medical therapies from the review as treatments are typically
-
psnet.ahrq.gov/node/44231/psn-pdf
January 22, 2016 - Just-in-time training for high-risk low-volume therapies:
an approach to ensure patient safety. … Just-in-Time Training for High-Risk Low-Volume Therapies: An
Approach to Ensure Patient Safety. … https://psnet.ahrq.gov/issue/just-time-training-high-risk-low-volume-therapies-approach-ensure-patient … and competency shortcomings for bedside
nurses on an as-needed basis, given the demands of complex treatments … https://psnet.ahrq.gov/issue/just-time-training-high-risk-low-volume-therapies-approach-ensure-patient-safety
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0399_01-07-2011.pdf
January 01, 2011 - Comparator(s): Comparisons of the above therapeutic interventions. … transarterial chemoembolization
(TACE) and radioembolization (RE)
Comparator(s): Comparisons of the above therapeutic … Comparator(s): Comparisons of the above therapeutic interventions. … What is the comparative effectiveness of local treatments for unresectable liver
metastases and unresectable … For metastatic liver disease, local therapy may be used in an attempt to prolong survival and/or to